Chickenpox in Adolescence

Introduction And Epidemiology

Chickenpox is a primary infection caused by the Varicella-Zoster Virus (VZV), a neurotropic alpha-herpesvirus.
While classically a benign childhood disease, it presents with significantly higher morbidity, mortality, and complication rates when it occurs in adolescents, defined roughly as 10 to 19 years of age.
In tropical and subtropical regions, the peak age of infection is frequently delayed, resulting in a higher proportion of susceptible adolescents who are at greater risk for severe disease.

VZV is highly contagious and spreads primarily via aerosolized respiratory droplets or through direct contact with vesicular fluid.
Patients remain infectious from 24 to 48 hours prior to rash onset until all skin lesions have completely crusted over, typically 4 to 7 days after the rash appears.
Following inhalation, the virus replicates in the upper respiratory tract and regional lymph nodes, constituting the primary viremia.
Subsequent secondary viremia disseminates the virus to the reticuloendothelial system, skin, and viscera.
The standard incubation period ranges from 10 to 21 days, averaging 14 to 16 days.

Adolescents frequently experience a distinct and severe prodrome lasting 24 to 48 hours prior to the appearance of the exanthem.
Symptoms include high fever reaching up to 41°C, profound malaise, anorexia, headache, and mild abdominal pain.
These systemic symptoms often persist for 2 to 4 days after the onset of the rash.

The rash begins as intensely pruritic erythematous macules that rapidly evolve into papules, followed by clear, fluid-filled vesicles classically described as a dewdrop on a rose petal.
Vesicles become cloudy and pustular within 24 to 48 hours, eventually umbilicating and crusting.
The distribution is characteristically centripetal, originating on the scalp, face, and trunk before spreading to the extremities.
A hallmark feature is cropping, defined as the simultaneous presence of lesions in all stages of evolution within the same anatomical area.
Adolescents consistently develop a higher burden of lesions, frequently exceeding 500, with new crops continuing to appear for more than 7 days.

Adolescents face a markedly increased risk of severe complications compared to young children.

Complication Category	Clinical Features
Varicella Pneumonia	The most serious complication in healthy adolescents, presenting 1 to 6 days post-rash with cough, dyspnea, tachypnea, and pleuritic chest pain; radiography reveals diffuse bilateral infiltrates.
Secondary Bacterial Infection	Superinfection of skin lesions by Staphylococcus aureus or Group A Streptococcus, manifesting as impetigo, cellulitis, or severe necrotizing fasciitis.
Neurological	Cerebellar ataxia presents with self-limiting gait disturbance and nystagmus; encephalitis presents with altered sensorium and seizures, carrying higher morbidity.
Hematologic And Systemic	Mild thrombocytopenia is common; rare complications include purpura fulminans, hepatitis, myocarditis, and nephritis.

Diagnosis remains primarily clinical, relying on the characteristic pleomorphic rash and exposure history.
Polymerase Chain Reaction (PCR) serves as the most sensitive diagnostic method, detecting VZV DNA in vesicular fluid or crusts.
Direct Fluorescence Assay provides rapid and specific detection utilizing cellular material from the vesicle base.
Tzanck smears reveal multinucleated giant cells but cannot distinguish VZV from Herpes Simplex Virus.

Antiviral therapy is universally recommended for all unvaccinated adolescents over 12 years of age due to the elevated risk of severe disease.
Therapy must be initiated within 24 hours of exanthem onset to ensure clinical efficacy.

Regimen Type	Pharmacological Guidelines
Oral First-Line	Acyclovir administered at 800 mg five times daily for 5 to 7 days, or Valacyclovir administered at 1000 mg three times daily for 5 days.
Intravenous Therapy	Intravenous Acyclovir administered at 10 mg/kg every 8 hours for 7 to 10 days; strictly reserved for severe complications like pneumonia or encephalitis.

Administer Paracetamol for fever control; Aspirin is strictly contraindicated due to the high risk of Reye syndrome.
Ibuprofen is generally avoided due to a theoretical risk of exacerbating severe streptococcal skin infections.
Utilize oral antihistamines and soothing lotions like calamine to manage intense pruritus.
Patients must be strictly isolated from school and public settings until every lesion has crusted over.

Unvaccinated adolescents strictly require a catch-up vaccination series consisting of two doses of the live-attenuated varicella vaccine separated by 4 to 8 weeks.
Following a susceptible exposure, administering the vaccine within 3 to 5 days provides effective post-exposure prophylaxis.
Varicella-Zoster Immune Globulin is reserved for high-risk exposed individuals who possess contraindications to the live vaccine.